Market Tracker

04/23 6:44am ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

311.68
Data as of Apr 22
 +9.68 / +3.21%
Today’s Change
206.30
Today|||52-Week Range
352.49
+13.24%
Year-to-Date

Today’s Trading

Previous close302.00
Today’s open302.76
Day’s range-- - --
Volume736,072
Average volume (3 months)1,181,787
Market cap$29.3B
Dividend yield--
Data as of 04/22/2014

Growth & Valuation

Earnings growth (last year)-43.56%
Earnings growth (this year)+21.19%
Earnings growth (next 5 years)+22.70%
Revenue growth (last year)+52.69%
P/E ratio81.8
Price/Sales12.80
Price/Book14.99

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...-0.73-1.44%
CBSTCubist Pharmaceutica...+3.06+4.70%
ISISIsis Pharmaceuticals...+1.94+5.53%
ALNYAlnylam Pharmaceutic...+2.61+4.68%
Data as of 04/22/2014

Financials

Next reporting dateMay 8, 2014
EPS forecast (this quarter)$2.19
Annual revenue (last year)$2.1B
Annual profit (last year)$424.4M
Net profit margin20.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts